Cree BAC, Freedman MS, Gold M, Pfleeger K, et al. Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Studies to Assess the Safety and Efficacy of Elezanumab when Added to Standard of Care in Relapsing and Progressive Forms of Multiple Sclerosis. Ann Neurol 2025 Jul 23. doi: 10.1002/ana.27262.
PMID: 40698976